The chemiluminescence immunoassay analyzer market size has grown strongly in recent years. It will grow from $6.03 billion in 2025 to $6.44 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to growth in clinical diagnostic testing volumes, increasing prevalence of infectious diseases, rising demand for accurate hormone testing, expansion of hospital laboratory infrastructure, growing adoption of automated laboratory systems.
The chemiluminescence immunoassay analyzer market size is expected to see strong growth in the next few years. It will grow to $8.15 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to rising burden of chronic and autoimmune diseases, increasing demand for early disease detection, expansion of diagnostic testing in emerging markets, growing focus on laboratory workflow efficiency, rising adoption of point-of-care immunoassay solutions. Major trends in the forecast period include rising demand for high-sensitivity diagnostic testing, increasing adoption of fully automated immunoassay systems, growing use of CLIA analyzers in infectious disease testing, expansion of CLIA applications in oncology and endocrinology, increasing preference for high-throughput laboratory analyzers.
The increasing prevalence of chronic diseases is expected to drive growth in the chemiluminescence immunoassay analyzer market in the coming years. Factors contributing to this rise include aging populations, unhealthy lifestyles, and advancements in medical care that extend the lifespan of individuals with acute conditions, thereby increasing the incidence of long-term health issues. Chemiluminescence immunoassay analyzers play a crucial role in managing chronic diseases by providing precise and sensitive detection of biomarkers, aiding in accurate diagnosis and monitoring of treatment effectiveness. For example, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023 approximately 194 million adults in the United States, or 76.4%, reported having at least one chronic condition. The prevalence stood at 59.5% among young adults, increased to 78.4% among midlife adults, and reached 93% among older adults. Therefore, the rising prevalence of chronic diseases is driving the growth of the chemiluminescence immunoassay analyzer market.
Leading companies in the chemiluminescence immunoassay analyzer market are focusing on developing advanced diagnostic technologies, such as automated analyzers, to enhance decision-making and analytical capabilities. Automated analyzers perform analytical processes automatically and are widely used in medical laboratories for efficient and accurate testing of samples. For instance, in July 2023, Fapon Biotech Inc., a China-based life sciences company, introduced the Shine i8000/9000 chemiluminescence immunoassay system. This high-speed, fully automated analyzer operates at an ultra-high throughput of 900 tests per hour, enabling partners to develop cutting-edge clinical diagnostic solutions. With initial results available in just 10 minutes, the system provides rapid insights crucial for time-sensitive situations. It boasts a rapid testing pace and high throughput capacity, efficiently managing large sample volumes while maintaining reliable accuracy, making it ideal for medium- to large-scale laboratories.
In November 2023, LASCCO, a Switzerland-based biotechnology company, and Abionic SA, also based in Switzerland, entered into a licensing agreement with Fapon, granting the company the rights to develop and commercialize the PSP (point-of-sample testing) technology. As part of the agreement, Fapon will integrate the PSP technology into its chemiluminescent immunoassay (CLIA) analyzer, with a focus on the Chinese market. Fapon Biotech is a China-based provider of comprehensive solutions in the in vitro diagnostics (IVD) industry.
Major companies operating in the chemiluminescence immunoassay analyzer market are F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Siemens Healthineers AG, Wiener Lab Group, PerkinElmer Inc., BioMérieux SA, Beckman Coulter Life Sciences, Tosoh Bioscience LLC, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., DiaSorin SpA, Euroimmun AG, Autobio Diagnostics Co. Ltd., Maccura Biotechnology Co. Ltd., Luminex Corporation, Fujirebio Holdings Inc., Randox Laboratories Ltd., Shenzhen Yhlo Biotech Co. Ltd., Addcare Bio-Tech Co. Ltd., Inova Diagnostics, Immunodiagnostic Systems Holdings (IDS), Dynex Technologies Inc., Nanjing Poclight Biotechnology Co. Ltd.
North America was the largest region in the chemiluminescence immunoassay analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemiluminescence immunoassay analyzer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chemiluminescence immunoassay analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the chemiluminescence immunoassay analyzer market by increasing costs for imported electronic components, optical systems, reagents, and precision manufacturing equipment used in analyzer production. These cost pressures have particularly affected fully automated and high-throughput analyzer segments, with asia-pacific and europe experiencing higher exposure due to globalized supply chains. Increased tariffs have raised capital equipment prices for hospitals and diagnostic laboratories and slowed procurement cycles. However, tariffs have also encouraged local manufacturing, regional assembly, and sourcing diversification, supporting long-term supply chain resilience.
The chemiluminescence immunoassay analyzer market research report is one of a series of new reports that provides chemiluminescence immunoassay analyzer market statistics, including chemiluminescence immunoassay analyzer industry global market size, regional shares, competitors with a chemiluminescence immunoassay analyzer market share, detailed chemiluminescence immunoassay analyzer market segments, market trends and opportunities, and any further data you may need to thrive in the chemiluminescence immunoassay analyzer industry. This chemiluminescence immunoassay analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Chemiluminescence immunoassay (CLIA) analyzers are sophisticated laboratory instruments used to detect and measure various substances such as proteins, hormones, and drugs in samples, employing chemiluminescence and immunoassay techniques. They are extensively utilized in clinical laboratories for their precise and automated detection capabilities, particularly for high-sensitivity detection of hormones, proteins, antibodies, and infectious agents.
The main types of CLIA analyzers include fully automated and semi-automated models. Fully automated CLIA analyzers are advanced devices that utilize chemiluminescence to automatically measure and analyze specific molecules in biological samples with high sensitivity and accuracy. They employ technologies such as sequential injection, random access, and batch analysis. These analyzers find applications in oncology, endocrinology, hepatitis and retroviruses, cardiac markers, infectious diseases, bone and mineral disorders, autoimmune diseases, allergies, gastrointestinal (GI) stool testing, and drug discovery and development. They are used by hospitals, clinics, medical laboratories, and pharmaceutical companies.
The chemiluminescence immunoassay analyzer market consists of sales of pacifier thermometers, automated instrumentation, quality control materials, and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The chemiluminescence immunoassay analyzer market size is expected to see strong growth in the next few years. It will grow to $8.15 billion in 2030 at a compound annual growth rate (CAGR) of 6%. The growth in the forecast period can be attributed to rising burden of chronic and autoimmune diseases, increasing demand for early disease detection, expansion of diagnostic testing in emerging markets, growing focus on laboratory workflow efficiency, rising adoption of point-of-care immunoassay solutions. Major trends in the forecast period include rising demand for high-sensitivity diagnostic testing, increasing adoption of fully automated immunoassay systems, growing use of CLIA analyzers in infectious disease testing, expansion of CLIA applications in oncology and endocrinology, increasing preference for high-throughput laboratory analyzers.
The increasing prevalence of chronic diseases is expected to drive growth in the chemiluminescence immunoassay analyzer market in the coming years. Factors contributing to this rise include aging populations, unhealthy lifestyles, and advancements in medical care that extend the lifespan of individuals with acute conditions, thereby increasing the incidence of long-term health issues. Chemiluminescence immunoassay analyzers play a crucial role in managing chronic diseases by providing precise and sensitive detection of biomarkers, aiding in accurate diagnosis and monitoring of treatment effectiveness. For example, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023 approximately 194 million adults in the United States, or 76.4%, reported having at least one chronic condition. The prevalence stood at 59.5% among young adults, increased to 78.4% among midlife adults, and reached 93% among older adults. Therefore, the rising prevalence of chronic diseases is driving the growth of the chemiluminescence immunoassay analyzer market.
Leading companies in the chemiluminescence immunoassay analyzer market are focusing on developing advanced diagnostic technologies, such as automated analyzers, to enhance decision-making and analytical capabilities. Automated analyzers perform analytical processes automatically and are widely used in medical laboratories for efficient and accurate testing of samples. For instance, in July 2023, Fapon Biotech Inc., a China-based life sciences company, introduced the Shine i8000/9000 chemiluminescence immunoassay system. This high-speed, fully automated analyzer operates at an ultra-high throughput of 900 tests per hour, enabling partners to develop cutting-edge clinical diagnostic solutions. With initial results available in just 10 minutes, the system provides rapid insights crucial for time-sensitive situations. It boasts a rapid testing pace and high throughput capacity, efficiently managing large sample volumes while maintaining reliable accuracy, making it ideal for medium- to large-scale laboratories.
In November 2023, LASCCO, a Switzerland-based biotechnology company, and Abionic SA, also based in Switzerland, entered into a licensing agreement with Fapon, granting the company the rights to develop and commercialize the PSP (point-of-sample testing) technology. As part of the agreement, Fapon will integrate the PSP technology into its chemiluminescent immunoassay (CLIA) analyzer, with a focus on the Chinese market. Fapon Biotech is a China-based provider of comprehensive solutions in the in vitro diagnostics (IVD) industry.
Major companies operating in the chemiluminescence immunoassay analyzer market are F. Hoffmann-La Roche AG, Abbott Laboratories Inc., Siemens Healthineers AG, Wiener Lab Group, PerkinElmer Inc., BioMérieux SA, Beckman Coulter Life Sciences, Tosoh Bioscience LLC, Bio-Rad Laboratories Inc., Shenzhen Mindray Bio-Medical Electronics Co. Ltd., DiaSorin SpA, Euroimmun AG, Autobio Diagnostics Co. Ltd., Maccura Biotechnology Co. Ltd., Luminex Corporation, Fujirebio Holdings Inc., Randox Laboratories Ltd., Shenzhen Yhlo Biotech Co. Ltd., Addcare Bio-Tech Co. Ltd., Inova Diagnostics, Immunodiagnostic Systems Holdings (IDS), Dynex Technologies Inc., Nanjing Poclight Biotechnology Co. Ltd.
North America was the largest region in the chemiluminescence immunoassay analyzers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chemiluminescence immunoassay analyzer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the chemiluminescence immunoassay analyzer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the chemiluminescence immunoassay analyzer market by increasing costs for imported electronic components, optical systems, reagents, and precision manufacturing equipment used in analyzer production. These cost pressures have particularly affected fully automated and high-throughput analyzer segments, with asia-pacific and europe experiencing higher exposure due to globalized supply chains. Increased tariffs have raised capital equipment prices for hospitals and diagnostic laboratories and slowed procurement cycles. However, tariffs have also encouraged local manufacturing, regional assembly, and sourcing diversification, supporting long-term supply chain resilience.
The chemiluminescence immunoassay analyzer market research report is one of a series of new reports that provides chemiluminescence immunoassay analyzer market statistics, including chemiluminescence immunoassay analyzer industry global market size, regional shares, competitors with a chemiluminescence immunoassay analyzer market share, detailed chemiluminescence immunoassay analyzer market segments, market trends and opportunities, and any further data you may need to thrive in the chemiluminescence immunoassay analyzer industry. This chemiluminescence immunoassay analyzer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Chemiluminescence immunoassay (CLIA) analyzers are sophisticated laboratory instruments used to detect and measure various substances such as proteins, hormones, and drugs in samples, employing chemiluminescence and immunoassay techniques. They are extensively utilized in clinical laboratories for their precise and automated detection capabilities, particularly for high-sensitivity detection of hormones, proteins, antibodies, and infectious agents.
The main types of CLIA analyzers include fully automated and semi-automated models. Fully automated CLIA analyzers are advanced devices that utilize chemiluminescence to automatically measure and analyze specific molecules in biological samples with high sensitivity and accuracy. They employ technologies such as sequential injection, random access, and batch analysis. These analyzers find applications in oncology, endocrinology, hepatitis and retroviruses, cardiac markers, infectious diseases, bone and mineral disorders, autoimmune diseases, allergies, gastrointestinal (GI) stool testing, and drug discovery and development. They are used by hospitals, clinics, medical laboratories, and pharmaceutical companies.
The chemiluminescence immunoassay analyzer market consists of sales of pacifier thermometers, automated instrumentation, quality control materials, and related products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Chemiluminescence Immunoassay Analyzer Market Characteristics
3. Chemiluminescence Immunoassay Analyzer Market Supply Chain Analysis
4. Global Chemiluminescence Immunoassay Analyzer Market Trends and Strategies
5. Chemiluminescence Immunoassay Analyzer Market Analysis of End Use Industries
7. Global Chemiluminescence Immunoassay Analyzer Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Chemiluminescence Immunoassay Analyzer Total Addressable Market (TAM) Analysis for the Market
9. Chemiluminescence Immunoassay Analyzer Market Segmentation
10. Chemiluminescence Immunoassay Analyzer Market Regional and Country Analysis
11. Asia-Pacific Chemiluminescence Immunoassay Analyzer Market
12. China Chemiluminescence Immunoassay Analyzer Market
13. India Chemiluminescence Immunoassay Analyzer Market
14. Japan Chemiluminescence Immunoassay Analyzer Market
15. Australia Chemiluminescence Immunoassay Analyzer Market
16. Indonesia Chemiluminescence Immunoassay Analyzer Market
17. South Korea Chemiluminescence Immunoassay Analyzer Market
18. Taiwan Chemiluminescence Immunoassay Analyzer Market
19. South East Asia Chemiluminescence Immunoassay Analyzer Market
20. Western Europe Chemiluminescence Immunoassay Analyzer Market
21. UK Chemiluminescence Immunoassay Analyzer Market
22. Germany Chemiluminescence Immunoassay Analyzer Market
23. France Chemiluminescence Immunoassay Analyzer Market
24. Italy Chemiluminescence Immunoassay Analyzer Market
25. Spain Chemiluminescence Immunoassay Analyzer Market
26. Eastern Europe Chemiluminescence Immunoassay Analyzer Market
27. Russia Chemiluminescence Immunoassay Analyzer Market
28. North America Chemiluminescence Immunoassay Analyzer Market
29. USA Chemiluminescence Immunoassay Analyzer Market
30. Canada Chemiluminescence Immunoassay Analyzer Market
31. South America Chemiluminescence Immunoassay Analyzer Market
32. Brazil Chemiluminescence Immunoassay Analyzer Market
33. Middle East Chemiluminescence Immunoassay Analyzer Market
34. Africa Chemiluminescence Immunoassay Analyzer Market
36. Chemiluminescence Immunoassay Analyzer Market Competitive Landscape and Company Profiles
37. Chemiluminescence Immunoassay Analyzer Market Other Major and Innovative Companies
40. Chemiluminescence Immunoassay Analyzer Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Chemiluminescence Immunoassay Analyzer Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses chemiluminescence immunoassay analyzer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for chemiluminescence immunoassay analyzer? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The chemiluminescence immunoassay analyzer market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Fully Automated Chemiluminescence Immunoassay Analyzers; Semi-Automated Chemiluminescence Immunoassay Analyzers2) By Technology: Sequential Injection; Random Access; Batch Analyzers
3) By Application: Oncology And Endocrinology; Hepatitis And Retroviruses; Cardiac Markers; Infectious Disease; Bone And Mineral Disorders; Auto-Immune Diseases; Allergy; Gastrointestinal (GI) Stool Testing; Drug Discovery And Development
4) By End User: Hospitals And Clinics; Medical And Diagnostic Laboratories; Pharmaceutical Companies
Subsegments:
1) By Fully Automated Chemiluminescence Immunoassay Analyzers: High-Throughput Analyzers; Medium-Throughput Analyzers; Low-Throughput Analyzers2) By Semi-Automated Chemiluminescence Immunoassay Analyzers: Bench-Top Analyzers; Portable Or Point-Of-Care Analyzers
Companies Mentioned: F. Hoffmann-La Roche AG; Abbott Laboratories Inc.; Siemens Healthineers AG; Wiener Lab Group; PerkinElmer Inc.; BioMérieux SA; Beckman Coulter Life Sciences; Tosoh Bioscience LLC; Bio-Rad Laboratories Inc.; Shenzhen Mindray Bio-Medical Electronics Co. Ltd.; DiaSorin SpA; Euroimmun AG; Autobio Diagnostics Co. Ltd.; Maccura Biotechnology Co. Ltd.; Luminex Corporation; Fujirebio Holdings Inc.; Randox Laboratories Ltd.; Shenzhen Yhlo Biotech Co. Ltd.; Addcare Bio-Tech Co. Ltd.; Inova Diagnostics; Immunodiagnostic Systems Holdings (IDS); Dynex Technologies Inc.; Nanjing Poclight Biotechnology Co. Ltd.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Chemiluminescence Immunoassay Analyzer market report include:- F. Hoffmann-La Roche AG
- Abbott Laboratories Inc.
- Siemens Healthineers AG
- Wiener Lab Group
- PerkinElmer Inc.
- BioMérieux SA
- Beckman Coulter Life Sciences
- Tosoh Bioscience LLC
- Bio-Rad Laboratories Inc.
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.
- DiaSorin SpA
- Euroimmun AG
- Autobio Diagnostics Co. Ltd.
- Maccura Biotechnology Co. Ltd.
- Luminex Corporation
- Fujirebio Holdings Inc.
- Randox Laboratories Ltd.
- Shenzhen Yhlo Biotech Co. Ltd.
- Addcare Bio-Tech Co. Ltd.
- Inova Diagnostics
- Immunodiagnostic Systems Holdings (IDS)
- Dynex Technologies Inc.
- Nanjing Poclight Biotechnology Co. Ltd.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 6.44 Billion |
| Forecasted Market Value ( USD | $ 8.15 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 24 |
